NEW YORK (GenomeWeb) – Exact Sciences reported after the close of the market on Thursday that its fourth quarter revenues rose 148 percent year over year, in line with its preliminary Q4 revenues as reported in early January.

For the three months ended Dec. 31, 2017, the molecular diagnostics company reported revenues of $87.4 million, up from $35.2 million in Q4 2016, and beating the analysts' average estimate of $85.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.